Brevan Howard Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Sell
8,952
-15,130
-63% -$573K ﹤0.01% 1593
2026
Q1
$861K Buy
+24,082
New +$876K 0.01% 993
2025
Q4
– Sell
-58,003
Closed -$1.64M – 1884
2025
Q3
$1.64M Buy
58,003
+20,618
+55% +$591K 0.01% 655
2025
Q2
$1.13M Sell
37,385
-34,908
-48% -$1.18M 0.01% 1007
2025
Q1
$2.96M Buy
72,293
+36,398
+101% +$1.75M 0.03% 225
2024
Q4
$1.95M Buy
35,895
+10,508
+41% +$602K 0.01% 288
2024
Q3
$1.65M Buy
25,387
+5,302
+26% +$341K 0.01% 313
2024
Q2
$1.24M Buy
20,085
+14,385
+252% +$999K 0.01% 316
2024
Q1
$483K Sell
5,700
-16,606
-74% -$1.32M ﹤0.01% 478
2023
Q4
$1.67M Buy
+22,306
New +$1.55M 0.02% 142

Other funds holding CRI

Brevan Howard Capital Management's CRI Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Carter's (CRI) stake by 63% in Q2 2026, selling an estimated $573K and leaving 8,952 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Brevan Howard Capital Management first reported a position in CRI in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.96M in Q1 2025. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Brevan Howard Capital Management held 8,952 shares of Carter's worth $368K as of Q2 2026.
  • Brevan Howard Capital Management sold 15,130 Carter's shares in Q2 2026, an estimated $573K.
  • Carter's made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1593 holding.
  • Brevan Howard Capital Management first reported a position in Carter's in Q4 2023 and has held it in 10 quarters since.
  • Brevan Howard Capital Management's Carter's position peaked at $2.96M in Q1 2025.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.